Evaluation of a group visit model for access to infant and toddler oral food challenges.

Evaluation of a group visit model for access to infant and toddler oral food challenges.
复制标题

DOI:
10.1016/j.jaip.2022.01.036
复制
发表时间:
2022-06
影响因子:
9.4
通讯作者:
Pistiner, Michael
Pistiner, Michael
中科院分区:
医学1区
文献类型:
--
作者:
Roy, Ian R.;Hazi, Arielle;Esteban, Cynthia A.;Andre, Mharlove;Virkud, Yamini;Shreffler, Wayne G.;Pistiner, Michael

文献摘要

参考文献

相似文献

14利益冲突:M。Pistiner曾在kaléo、Novartis、15 FoodGraph和DBV Technologies的科学顾问委员会任职;接受过kaléo、DBV Technologies、Egg 16 Nutrition Center和National Peanut Board的资助;是AllergyHome和17 Allergy Certified Training的联合创始人。Y. Virkud曾担任DBV Technologies的顾问。WG 18 Shreffler是Aimmune Therapeutics的科学委员会顾问,也是FARE的医学顾问19;曾在DBV技术,赛诺菲,诺华和葛兰素史克的顾问小组任职;并获得了DBV技术,Aimmune,21和Vedanta的临床试验资金。IR Roy,A. Hazi,M. André和CA Esteban报告没有相关的利益冲突。23
14 Conflicts of Interest: M. Pistiner has served on scientific advisory boards of kaléo, Novartis, 15 FoodGraph, and DBV Technologies; received funding from kaléo, DBV Technologies, Egg 16 Nutrition Center, and the National Peanut Board; and is a co-founder of AllergyHome and 17 Allergy Certified Training. Y. Virkud has served as a consultant for DBV Technologies. WG 18 Shreffler is on the Scientific Board Advisory of Aimmune Therapeutics and is a medical advisor 19 for FARE; served on advisory panels for DBV technologies, Sanofi, Novartis, and 20 GlaxoSmithKline; and has received clinical trial funding from DBV Technologies, Aimmune, 21 and Vedanta. IR Roy, A. Hazi, M. André, and CA Esteban report no relevant conflicts of 22 interest. 23
DOI: 10.1016/j.jaci.2010.10.007
发表时间: 2010-12
期刊: The Journal of allergy and clinical immunology
影响因子: --
作者:
NIAID-Sponsored Expert Panel;Boyce JA;Assa'ad A;Burks AW;Jones SM;Sampson HA;Wood RA;Plaut M;Cooper SF;Fenton MJ;Arshad SH;Bahna SL;Beck LA;Byrd-Bredbenner C;Camargo CA Jr;Eichenfield L;Furuta GT;Hanifin JM;Jones C;Kraft M;Levy BD;Lieberman P;Luccioli S;McCall KM;Schneider LC;Simon RA;Simons FE;Teach SJ;Yawn BP;Schwaninger JM
通讯作者: Schwaninger JM
DOI: 10.1016/j.jaci.2020.11.033
发表时间: 2021-03
期刊: The Journal of allergy and clinical immunology
影响因子: --
作者:
Keet C;Pistiner M;Plesa M;Szelag D;Shreffler W;Wood R;Dunlop J;Peng R;Dantzer J;Togias A
通讯作者: Togias A
3岁以下儿童的口服食物挑战结果。
DOI: 10.1016/j.jaip.2020.06.035
发表时间: 2020-11
期刊: The journal of allergy and clinical immunology. In practice
影响因子: --
作者:
Esteban CA;Shreffler WG;Virkud YV;Pistiner M
通讯作者: Pistiner M
DOI: 10.1016/j.jaip.2020.07.035
发表时间: 2020-11-01
影响因子: 9.4
作者:
Greiwe, Justin;Oppenheimer, John;Greenhawt, Matthew
通讯作者: Greenhawt, Matthew
DOI: 10.1186/s40413-016-0137-9
发表时间: 2017-01-06
影响因子: 5.1
作者:
Togias, Alkis;Cooper, Susan F.;Boyce, Joshua A.
通讯作者: Boyce, Joshua A.